Canaccord Genuity analyst John Newman maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) today and set a price target of ...

In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...

Middleby (NASDAQ:MIDD – Get Free Report) had its price objective increased by equities research analysts at Canaccord Genuity ...

Stride (NYSE:LRN – Get Free Report) had its price target increased by investment analysts at Canaccord Genuity Group from ...

Canaccord Genuity adjusted its outlook on Akero Therapeutics (NASDAQ: NASDAQ:AKRO) shares, raising the price target to $73 ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.82% of ...

Canaccord Genuity reaffirmed its confidence in Natera (NASDAQ:NTRA), currently trading at $168.73 with a market cap of $22.3 billion, by maintaining a Buy rating and a price target of $180.00.

Odd Burger Corporation ("Odd Burger" or the "Company") (TSXV: ODD) (OTCPK: ODDAF) (FSE: IA9) is pleased to announce that it ...

Here’s a simple example. Your client holds shares of Microsoft Corp., listed on the New York Stock Exchange. They’ve decided ...

Canadian Investment Regulatory Organization (CIRO) Logo (CNW Group/Canadian Investment ... advisor at a Calgary branch of Canaccord Genuity Corp. He is currently not registered in the securities ...

Notice of Hearing and Statement of Allegations At all material times, William Robert Hall was an investment advisor at a Calgary branch of Canaccord Genuity Corp. He is currently not registered in ...

An aggregate of 12,248,235 units of the Company ("Units") were sold under the Offering at a price of C$0.18 per Unit (the "Issue Price") for gross proceeds of C$2,204,682. Canaccord Genuity Corp ...